H.I.G. Capital, a global alternative investment firm, agreed to acquire a 75% stake in Navitas Life Sciences, a provider of full-service CRO, FSP expertise in data sciences, and regulatory and safety solutions for large blue chip pharmaceutical and biotech clients, from TAKE Solutions, a globally recognized domain intensive services provider in life sciences, for $102m. "We are delighted to partner with H.I.G. in our mission to accelerate access to outstanding drug development outcomes to people across the world by harnessing the power of technology and domain knowledge. H.I.G., with its global network and diverse experience across healthcare and life sciences, makes them an ideal partner to support Navitas’ continued growth as a Global Next Generation CRO," Srinivasan H R, TAKE Solutions Vice Chairman and Managing Director.